![The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis](https://www.natap.org/2011/images/040111/methods.gif)
The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis
![PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis](https://i1.rgstatic.net/publication/345943346_ASPIRE_trial_study_protocol_for_a_double-blind_randomised_controlled_trial_of_aspirin_for_overheating_during_exercise_in_multiple_sclerosis/links/60194c3e299bf1b33e40bbbb/largepreview.png)
PDF) ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis
![Design of the randomized, open-label, multicenter, phase III ASPIRE... | Download Scientific Diagram Design of the randomized, open-label, multicenter, phase III ASPIRE... | Download Scientific Diagram](https://www.researchgate.net/publication/330147847/figure/fig1/AS:711526398836736@1546652521315/Design-of-the-randomized-open-label-multicenter-phase-III-ASPIRE-trial-KRd-vs-Rd.png)